Suraksha Diagnostic Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 0.50 per equity share.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Suraksha Diagnostic's Board approved FY2025-26 standalone revenue of Rs. 30,068 lakhs (+20.7% YoY) and consolidated revenue of Rs. 31,041 lakhs (+23.1% YoY). Standalone PAT grew to Rs. 3,406 lakhs (vs Rs. 3,344 lakhs) and consolidated PAT stood at Rs. 3,140 lakhs (vs Rs. 3,098 lakhs). Consolidated EPS is Rs. 6.18. The Board recommended a maiden/reinstated dividend of Rs. 0.50 per equity share (25% on face value of Rs. 2), subject to shareholder approval at the 21st AGM on September 2, 2026. Record date is August 26, 2026. Note: FY2024-25 paid Nil dividend, making this a resumed payout.
The dividend signals a return to shareholder payouts after a nil dividend last year, reflecting improved cash generation. However, at Rs. 0.50 per share, the absolute quantum is modest and unlikely to materially move the stock.